💰 CIC’s recurring EPS grew by 17.7% YoY LKR 0.75 (previous: LKR 0.64), stemming from PATMI of LKR 1.5bn in 1Q FY27. Topline and EBIT margin growth stemmed from the industrial solutions and livestock solutions segments offsetting the degrowth from the Agri cluster. 📘 BRS Outlook: We expect CIC’s diversified earnings and competitive market position to navigate external stress. Staggered cultivation schedule across the major agricultural zones would minimise the negative impact from adverse weather on Agri segments. We anticipate Healthcare margins to recover during the 2H FY27E while industrial solutions is expected to sustain its momentum. Near term outlook for CIC’s livestock segment remains positive aided by healthy demand for poultry and Day Old Chicks (DOCs).